Vynca

• 31/01/2022
• Series C
• $30,000,000

Vynca enables high-quality, person-centered, goal-concordant care that reflects individuals’ wishes with their serious illness management platform that incorporates virtual palliative care services, advance care planning, care coordination, symptom management, whole-person care and provider engagement. The company’s comprehensive solution set empowers providers, individuals and their families to have meaningful conversations about future care preferences supported by a broad range of serious illness management services offered from a single point of trust to deliver successful value-based arrangements to healthcare organizations. With this approach, Vynca is able to ensure that personalized end-of-life care is available for every individual, every time.

---

---